Chordia Therapeutics Inc. (TYO:190A)
Japan
· Delayed Price · Currency is JPY 227.00
+2.00 (0.89%)
May 30, 2025, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 15.66 billion as of May 30, 2025.
Market Cap
15.66B
Enterprise Value
12.38B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
227.00
Market Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has increased from 12.58B to 15.66B, an increase of 24.44%. That is a compound annual growth rate of 25.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 15.66B | -26.77% |
| Dec 30, 2024 | 21.39B | 69.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.33T |
| Daiichi Sankyo Company | 7,326.61B |
| Takeda Pharmaceutical Company | 6,594.08B |
| HOYA Corporation | 6,018.59B |
| Terumo | 4,017.77B |
| Otsuka Holdings | 3,583.88B |
| Astellas Pharma | 2,507.05B |
| Olympus | 2,056.00B |